For those suffering with Alzheimer’s disease or the onset of the condition, the medication prescribed can lead to a series of side effects that can greatly inhibit the body's other receptors and cause more stress on the individual. Luckily Stanford University has put together a small golden ball that is designed as a nanoparticle that dispenses medication in a much more precise manner, to eliminate the blocking of all of the body's receptors. This ensures that only those receptors affected by the Alzheimer’s are treated.
Currently Alzheimer’s disease can be a result of the NMDA receptor having too much stimulation, but often times the treatment options block the rest of the receptors as well. The newly developed gold nanoparticle will be able to tell the difference between the receptors, and dispense the medication accordingly with much more precision.
More Stats +/-
Health-Improving Cognitive Charts
Memory Loss Simulators
Alzheimer's Awareness Exhibits
Free 2019 Report & eBook
Get the top 100 trends happening right NOW -- plus a FREE copy of our award-winning book.
Our Research Methodology
This article is one of 350,000 experiments. We use crowd filtering, big data and AI to identify insights.